The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute ...

The Ministry of Health and Ministry of External Affairs procured the vaccine and coordinated its dispatch with the help of the High Commiss...

The reasons for the lower SARS-CoV-2 antibody levels in the BCG group were not clear.

Trials showed that BCG vaccine, which is used for protection against tuberculosis for more than 40 years now, triggered antibody and T-cell...

The University of Exeter in south-west England said on Sunday that it is leading the UK arm of the worldwide research called the BCG vaccin...

Bacillus Calmette-Guerin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been sh...

However the study, published in the journal Cell, cautioned that it is unclear whether the vaccine can prevent COVID-19 in the older sectio...

The paper published in Science Advances, a peer-reviewed medical journal brought out by the American Association for the Advancement of Sci...

The study sponsored by the ICMR will recruit 1,450 elderly individuals within the ages of 60 and 99 with no preexisting conditions such as ...

This is significant as the study will see whether the vaccine’s potential to combat Covid-19 and prevent hospitalisation among the aged as ...

The bacille Calmette-Gurin (BCG) vaccine has a documented protective effect against meningitis and disseminated TB in children, according t...

The statement gains significance for countries including India, where some states are considering using the BCG vaccine for clinical trials...

"We found that countries without universal policies of BCG vaccination, such as Italy, the Netherlands, and the United States, have been mo...

Study co-authored by Indian-American cancer surgeon comes even as clinical trials on the efficacy of BCG vaccine for Covid-19 are underway.

With nearly 900,000 cases and 45,000 deaths, the world is struggling to control Covid-19.

GSBPL is one of the four companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF.

Scientists have found that a variant of an existing vaccine offers stronger protection against both tuberculosis and leprosy.